Abstract

The infection of chickens with avian Hepatitis E virus (avian HEV) can be asymptomatic or induces clinical signs characterized by increased mortality and decreased egg production in adult birds. Due to the lack of an efficient cell culture system for avian HEV, the interaction between virus and host cells is still barely understood. In this study, four truncated avian HEV capsid proteins (ORF2-1 – ORF2-4) with an identical 338aa deletion at the N-terminus and gradual deletions from 0, 42, 99 and 136aa at the C-terminus, respectively, were expressed and used to map the possible binding site within avian HEV capsid protein. Results from the binding assay showed that three truncated capsid proteins attached to avian LMH cells, but did not penetrate into cells. However, the shortest construct, ORF2-4, lost the capability of binding to cells suggesting that the presence of amino acids 471 to 507 of the capsid protein is crucial for the attachment. The construct ORF2-3 (aa339-507) was used to study the potential binding of avian HEV capsid protein to human and other avian species. It could be demonstrated that ORF2-3 was capable of binding to QT-35 cells from Japanese quail and human HepG2 cells but failed to bind to P815 cells. Additionally, chicken serum raised against ORF2-3 successfully blocked the binding to LMH cells. Treatment with heparin sodium salt or sodium chlorate significantly reduced binding of ORF2-3 to LMH cells. However, heparinase II treatment of LMH cells had no effect on binding of the ORF2-3 construct, suggesting a possible distinct attachment mechanism of avian as compared to human HEV. For the first time, interactions between avian HEV capsid protein and host cells were investigated demonstrating that aa471 to 507 of the capsid protein are needed to facilitate interaction with different kind of cells from different species.

Highlights

  • Beside asymptomatic infections, avian hepatitis E virus has been identified as etiological agent of two syndromes: big liver and spleen disease and hepatitis-splenomegalyPLOS ONE | DOI:10.1371/journal.pone.0153723 April 13, 2016Avian Hepatitis E Virus ORF2 Binding Assay syndrome [1]

  • Highest molecular weight of ORF2-1oligomers observed in Western blotting analysis was more than 260KDa and trimers of ORF2-3 and ORF2-4 were revealed with molecular weight of about 70KDa to 50KDa, respectively (Fig 1c)

  • The results showed successful blocking of ORF2-3 binding to LMH cells by pre-treatment of ORF2-3 with a chicken anti-serum in comparison to a negative control serum (Fig 6b)

Read more

Summary

Introduction

Avian hepatitis E virus (avian HEV) has been identified as etiological agent of two syndromes: big liver and spleen disease and hepatitis-splenomegalyPLOS ONE | DOI:10.1371/journal.pone.0153723 April 13, 2016Avian Hepatitis E Virus ORF2 Binding Assay syndrome [1]. Avian hepatitis E virus (avian HEV) has been identified as etiological agent of two syndromes: big liver and spleen disease and hepatitis-splenomegaly. Big liver and spleen disease was first recognized in Australia in the 1980s as an economically important disease of broiler breeders. Hepatitis–splenomegaly syndrome was described in the United States as a disease that causes slightly increased mortality and decreased egg production in broiler breeders and laying hens [2,3]. The presence of avian HEV has been widely detected around the world like in China [5], Australia [6], Korea [7], United States [8] and Europe [6,9,10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call